President Donald Trump speaks during an event about prescription drug prices with Health and Human Services Secretary Alex Azar in the Rose Garden of the White House in Washington, Friday, May 11, 2018. (AP Photo/Carolyn Kaster)
Big Pharma

Trump’s Promise to Cut Drug Prices Turns Into Another Ploy to Enrich Industry, Blame Foreigners

He calls it “American patients first,” and takes aim at what he calls “foreign freeloading.”

by Robert Reich

Big Pharma, Big Oil and Big Banks Meet the Definition of Terrorists

Common threads persist throughout definitions of terrorism: violence, injury or death, intimidation, intentionality, multiple targets and political motivation. Big pharma, big oil and big banks meet them all.

Big Pharma, Big Oil and Big Banks Meet the Definition of Terrorists

Various definitions of terrorism have been proposed in recent years, by organizations such as the FBI, the 

Read Full Article

Be Sociable, Share!

Paul Buchheit

Paul Buchheit

Paul Buchheit is a college teacher, an active member of US Uncut Chicago, founder and developer of social justice and educational websites (UsAgainstGreed.org, PayUpNow.org, RappingHistory.org), and the editor and main author of "American Wars: Illusions and Realities" (Clarity Press). He can be reached at paul@UsAgainstGreed.org.

You Might Also Like

Harvard Study: Spike In US Drug Prices Stem From Gov. Granted Monopoly Rights

Consistently, Big Pharma has defended high cost of drugs in the United States, claiming it as a direct result of high research costs associated with the development of drugs.

Harvard Study: Spike In US Drug Prices Stem From Gov. Granted Monopoly Rights

A new study by the medical school of Harvard University in Cambridge, Massachusetts has revealed that the high cost of drugs in the United States is due to the country’s government granting

Read Full Article

Be Sociable, Share!

You Might Also Like

Study: Docs Who Get Company Cash Prescribe More Brand-Name Meds

The more money doctors receive from drug and medical device companies, the more brand-name drugs they tend to prescribe, a new ProPublica analysis shows. Even a meal can make a difference.

Study: Docs Who Get Company Cash Prescribe More Brand-Name Meds

Doctors have long disputed that the payments they receive from pharmaceutical companies have any relationship to how they prescribe drugs. There’s been little evidence to settle the matter — until now. A ProPublica analysis has found for the first time that doctors who receive payments from the medical industry do indeed tend to prescribe

Read Full Article

Be Sociable, Share!

You Might Also Like

FDA Policy: Big Pharma Firms Pay To Play

‘Instead of protecting the public health, the FDA has been allowing the drug companies to pay for a seat at a small table where all the rules were written.’

FDA Policy: Big Pharma Firms Pay To Play

Major pharmaceutical companies are engaging in "pay to play" arrangements that allow them to shape public policy on painkiller testing rules and regulations, according to e-mails obtained by a public records request. The Washington Post

Read Full Article

Be Sociable, Share!

You Might Also Like